Daily News Podcast

Opioids don’t top NSAIDs for chronic pain


 

Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

Dialing back opioids for chronic pain one conversation at a time
MDedge Family Medicine
Opioids appear safe for sickle cell pain
MDedge Family Medicine
Comorbid TBI & PTSD raise the risk for sleep disturbances, pain
MDedge Family Medicine
Epistaxis: A guide to assessment and management
MDedge Family Medicine
A case of cold burn reported with whole-body cryotherapy
MDedge Family Medicine
“FAST” indices help to identify fibromyalgia in routine rheumatology care
MDedge Family Medicine
USPSTF issues draft research plan on opioid use disorder prevention
MDedge Family Medicine
Rheumatologist prescribing rates predict chronic opioid use in RA patients
MDedge Family Medicine
Opioid benefit small in chronic noncancer pain
MDedge Family Medicine
Insulin loses its starting spot
MDedge Family Medicine